Zobrazeno 1 - 10
of 72
pro vyhledávání: '"D. Van Amerongen"'
Autor:
Donna A. Messner, J Al Naber, J. Tyrone, Lon S. Schneider, D. Van Amerongen, O. Dabbous, S. Gabler, P. Rabins, M. Irizarry, D. Wuest, E. Payzant, Norman L. Foster, D. Lotz, Howard Fillit, R. Krakauer, A. C. Downing
Publikováno v:
The Journal Of Prevention of Alzheimer's Disease. :1-7
BACKGROUND: Drug development for disease modifying agents in Alzheimer’s disease (AD) is focused increasingly on targeting underlying pathology in very early stages of AD or in cognitively normal patients at elevated risk of developing dementia due
Autor:
Brandon T. Suehs, C. Wallick, S. Seleri, D. van Amerongen, R. DeClue, M. Ruble, D. Choi, Ibrahim M Abbass
Publikováno v:
Value in Health. 23:S269
Autor:
M. Ruble, Brandon T. Suehs, D. Choi, R. DeClue, D. van Amerongen, Ibrahim M Abbass, S. Seleri, C. Wallick
Publikováno v:
Value in Health. 23:S270
Autor:
Martin Heinrichs, Lisette Jansen in de Wal, Rob C J Stooker, Ted S G A M van den Ingh, Johan D van Amerongen, Johannes H. van der Kolk
Publikováno v:
American Journal of Veterinary Research. 65:1701-1707
Objective—To determine size and weight of the pituitary gland and associations between pituitary gland size and weight and sex and age in horses without clinical signs associated with pituitary pars intermedia adenoma (PPIA) and horses and ponies w
Autor:
D van Amerongen
Publikováno v:
Cancer Control. 7:462-468
Publikováno v:
Value in Health. 16(3)
Autor:
D, van Amerongen
Publikováno v:
Oncology (Williston Park, N.Y.). 14(11A)
The role of managed-care organizations (MCOs) is to determine the existence of a benefit and how it is to be covered. Clinical guidelines and evidence-based medicine are critical parts of those decisions, and help drive much of the medical policies o
Autor:
D, van Amerongen
Publikováno v:
Physician executive. 25(1)
Since the turn of the century, we have gone from medicine as a cottage industry, based largely on barter, to the complex entity it is today. What we will see in the coming decade, if not sooner is the emergence of the next level of managed care. As m
Autor:
D, van Amerongen
Publikováno v:
Physician executive. 24(6)
With the increase in the requests for high intensity medical procedures such as organ transplantation, the physician executive often is placed in the middle between competing interests. Whether he or she represents the provider or payer side, there i
Autor:
D, van Amerongen
Publikováno v:
Physician executive. 23(5)
At first glance, it may appear as if managed care itself may be doomed. The avalanche of bills, measures, initiatives, Federal regulations, etc., seemed overwhelming in late 1996. Did this, in fact, portend a national shift away from managed care? Wh